Major channels involved in neuropsychiatric disorders and therapeutic perspectives
- PMID: 23675382
- PMCID: PMC3646240
- DOI: 10.3389/fgene.2013.00076
Major channels involved in neuropsychiatric disorders and therapeutic perspectives
Abstract
Voltage-gated ion channels are important mediators of physiological functions in the central nervous system. The cyclic activation of these channels influences neurotransmitter release, neuron excitability, gene transcription, and plasticity, providing distinct brain areas with unique physiological and pharmacological response. A growing body of data has implicated ion channels in the susceptibility or pathogenesis of psychiatric diseases. Indeed, population studies support the association of polymorphisms in calcium and potassium channels with the genetic risk for bipolar disorders (BPDs) or schizophrenia. Moreover, point mutations in calcium, sodium, and potassium channel genes have been identified in some childhood developmental disorders. Finally, antibodies against potassium channel complexes occur in a series of autoimmune psychiatric diseases. Here we report recent studies assessing the role of calcium, sodium, and potassium channels in BPD, schizophrenia, and autism spectrum disorders, and briefly summarize promising pharmacological strategies targeted on ion channels for the therapy of mental illness and related genetic tests.
Keywords: autism; bipolar disorders; ion channel openers; ion channels; ion channels blockers; schizophrenia.
Figures

Similar articles
-
Genetic Associations between Voltage-Gated Calcium Channels and Psychiatric Disorders.Int J Mol Sci. 2019 Jul 19;20(14):3537. doi: 10.3390/ijms20143537. Int J Mol Sci. 2019. PMID: 31331039 Free PMC article. Review.
-
Voltage Gated Ion Channels and Sleep.J Membr Biol. 2024 Dec;257(5-6):269-280. doi: 10.1007/s00232-024-00325-0. Epub 2024 Oct 1. J Membr Biol. 2024. PMID: 39354150 Review.
-
Calcium Channels, Synaptic Plasticity, and Neuropsychiatric Disease.Neuron. 2018 May 2;98(3):466-481. doi: 10.1016/j.neuron.2018.03.017. Neuron. 2018. PMID: 29723500 Review.
-
Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders.Prog Neurobiol. 2015 Nov;134:36-54. doi: 10.1016/j.pneurobio.2015.09.002. Epub 2015 Sep 16. Prog Neurobiol. 2015. PMID: 26386135 Free PMC article. Review.
-
Utilising Automated Electrophysiological Platforms in Epilepsy Research.Methods Mol Biol. 2021;2188:133-155. doi: 10.1007/978-1-0716-0818-0_7. Methods Mol Biol. 2021. PMID: 33119850
Cited by
-
Neuroprotective Effect of Codonopsis pilosula Polysaccharide on Aβ25-35-Induced Damage in PC12 Cells via the p38MAPK Signaling Pathways.Pharmaceuticals (Basel). 2024 Sep 18;17(9):1231. doi: 10.3390/ph17091231. Pharmaceuticals (Basel). 2024. PMID: 39338393 Free PMC article.
-
Long QT syndrome is associated with an increased burden of diabetes, psychiatric and neurological comorbidities: a nationwide cohort study.Open Heart. 2019 Oct 28;6(2):e001161. doi: 10.1136/openhrt-2019-001161. eCollection 2019. Open Heart. 2019. PMID: 31749975 Free PMC article.
-
Contribution of Axon Initial Segment Structure and Channels to Brain Pathology.Cells. 2023 Apr 21;12(8):1210. doi: 10.3390/cells12081210. Cells. 2023. PMID: 37190119 Free PMC article. Review.
-
Identification and functional characterization of two novel mutations in KCNJ10 and PI4KB in SeSAME syndrome without electrolyte imbalance.Hum Genomics. 2019 Oct 22;13(1):53. doi: 10.1186/s40246-019-0236-0. Hum Genomics. 2019. PMID: 31640787 Free PMC article.
-
The ROCK Inhibitor Fasudil and Sertraline Share Morphological and Molecular Effects in the Hippocampus of Chronically Stressed Rats: Exploring Common Antidepressant Pathways by Network Pharmacology.ACS Pharmacol Transl Sci. 2025 Apr 3;8(5):1292-1312. doi: 10.1021/acsptsci.4c00680. eCollection 2025 May 9. ACS Pharmacol Transl Sci. 2025. PMID: 40370991
References
-
- Aldana B. I., Sitges M. (2012). Sertraline inhibits pre-synaptic Na+ channel-mediated responses in hippocampus hippocampus-isolated nerve endings. J. Neurochem. 121 197–205 - PubMed
-
- Altamura A. C., Lietti L., Dobrea C., Benatti B., Arici C, Dell’Osso B. (2011). Mood stabilizers for patients with bipolar disorder: the state of the art. Expert Rev. Neurother. 11 85–99 - PubMed
-
- Apud J. A., Zhang F., Decot H., Bigos K. L., Weinberger D. R. (2012). Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophrenia. Am. J. Psychiatry 169 725–734 - PubMed
-
- Askland K. (2006). Toward a biaxial model of “bipolar” affective disorders: further exploration of genetic, molecular and cellular substrates. J. Affect. Disord. 94 35–66 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources